Divya Bhamidipati is an Infectious Disease physician. OpenAlex indexes 20 publications with 633 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6410 Fannin St Ste 600
Houston, TX 770305206
Telephone
713-500-6767Provider last certified this registry record 23 Jun 2025.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20241 payment
- Gilead Sciences, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
61.7%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor37.1%Triumeq52%Descovy48%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor18%Tivicay100%Part D<11 patients+ 1 more class in this area
Cardiovascular
18.6%Statin12%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker6.6%Nifedipine Er100%Part D<11 patientsRespiratory
6.6%Opioid Agonist6.6%Hydrocodone-Acetaminophen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022
MMWR Morbidity and Mortality Weekly Report
2022 - Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
The Lancet Respiratory Medicine
2022 - An initiative to increase organ donor registration among persons with HIV
American Journal of Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”